Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3IK7O
|
|||
| Drug Name |
NYX-783
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Post-traumatic stress disorder [ICD-11: 6B40; ICD-10: F43.1, F62.0; ICD-9: 309.81] | Phase 2 | [1] | |
| Company |
Aptinyx
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04044664) Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Aptinyx. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.